Sodium intake and metabolic syndrome: A systematic review;Consumo de sódio e síndrome metabólica: Uma revisão sistemática

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 53, Issue 5, 2009, Pages 608-616

  Sarno, Flávio ^a   Jaime, Patricia Constante ^a   Ferreira, Sandra Roberta G ^a   Monteiro, Carlos Augusto ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Dietary sodium; Hypertension; Insulin resistance; Metabolic syndrome; Sodium restricted diet

Indexed keywords

ARTICLE; BLOOD PRESSURE; DRUG EFFECT; FEMALE; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; PATHOPHYSIOLOGY; PHYSIOLOGY; SALT INTAKE;

BLOOD PRESSURE; FEMALE; HUMANS; HYPERTENSION; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; SODIUM CHLORIDE, DIETARY;

EID: 70349941070     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/s0004-27302009000500013     Document Type: Article

References (52)

1. Reaven GM. Banting lecture 1988. Role of insulin resistance inhuman disease. Diabetes. 1988;37(12):1595-607.
2. Kahn R, Buse J, Ferrannini E, Stern M, American Diabetes A, European Association for the Study of D. The metabolic syndrome:time for a critical appraisal: joint statement from the AmericanDiabetes Association and the European Association for the Studyof Diabetes. Diabetes Care. 2005;28(9):2289-304.
3. Levesque J, Lamarche B. The metabolic syndrome: definitions,prevalence and management. J Nutrigenet Nutrigenomics. 2008;1:100-8.
4. WHO. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Report of aWHO consultation: WHO/NCD/NCS1999 Contract 99.2.
5. Balkau B, Charles MA. Comment on the provisional report fromthe WHO consultation. European Group for the Study of InsulinResistance (EGIR). Diabet Med. 1999;16(5):442-3.
6. III ATP. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection,Evaluation, and Treatment of High Blood Cholesterol in Adults.JAMA. 2001;285(19):2486-97.
7. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C, American Heart A, et al. Definition of metabolic syndrome: reportof the National Heart, Lung, and Blood Institute/American HeartAssociation conference on scientific issues related to definition.Circulation. 2004;109(3):433-8.
8. Bloomgarden ZT. American Association of Clinical Endocrinologists (AACE) consensus conference on the insulin resistancesyndrome: 25-26 August 2002, Washington, DC. Diabetes Care. 2003;26(3):933-9.
9. Bloomgarden ZT. American Association of Clinical Endocrinologists (AACE) consensus conference on the insulin resistancesyndrome: 25-26 August 2002, Washington, DC. Diabetes Care. 2003;26(4):1297-303.
10. Einhorn D, Reaven GM, Cobin RH, Ford E, Ganda OP, Handelsman Y, et al. American College of Endocrinology position statement onthe insulin resistance syndrome. Endocr Pract. 2003;9(3):237-52.
11. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome: a new worldwide definition. A Consensus Statement from the InternationalDiabetes Federation. Diabet Med. 2006;23(5):469-80.
12. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome:an American Heart Association/National Heart, Lung, and BloodInstitute Scientific Statement. Circulation. 2005;112(17):2735-52.
13. Sociedade Brasileira de H, Sociedade Brasileira de C, SociedadeBrasileira de Endocrinologia e M, Sociedade Brasileira de D, Sociedade Brasileira de Estudos da O. [I Brazilian guidelines on diagnosis and treatment of metabolic syndrome]. Arq Bras Cardiol. 2005;84 Suppl 1:1-28.
14. American Diabetes A. Diagnosis and classification of diabetesmellitus. Diabetes Care. 2004;27 Suppl 1:S5-10.
15. Gallagher EJ, LeRoith D, Karnieli E. The metabolic syndrome -from insulin resistance to obesity and diabetes. Endocrinol Metab Clin North Am. 2008;37(3):559-79, vii.
16. Kressel G, Trunz B, Bub A, Hulsmann O, Wolters M, Lichtinghagen R, et al. Systemic and vascular markers of inflammation in relation to metabolic syndrome and insulin resistance in adults withelevated atherosclerosis risk. Atherosclerosis. 2009;202(1):263-71.
17. Goossens GH. The role of adipose tissue dysfunction in thepathogenesis of obesityrelated insulin resistance. Physiol Behav. 2008;94(2):206-18.
18. Lara-Castro C, Garvey WT. Intracellular lipid accumulation in liverand muscle and the insulin resistance syndrome. Endocrinol Metab Clin North Am. 2008;37(4):841-56.
19. Grattagliano I, Palmieri VO, Portincasa P, Moschetta A, Palasciano G. Oxidative stressinduced risk factors associated with themetabolic syndrome: a unifying hypothesis. J Nutr Biochem. 2008;19(8):491-504.
20. Briana D, Malamitsi-Puchner A. Intrauterine growth restrictionand adult disease: the role of adipocytokines. Eur J Endocrinol. 2009;160(3):337-47.
21. Sjostrand M, Eriksson JW. Neuroendocrine mechanisms in insulin resistance. Mol Cell Endocrinol. 2009;297(1-2):104-11.
22. Esposito K, Ceriello A, Giugliano D. Diet and the metabolic syndrome. Metab Syndr Relat Disord. 2007;5(4):291-6.
23. Lakka TA, Laaksonen DE. Physical activity in prevention andtreatment of the metabolic syndrome. Appl Physiol Nutr Metab. 2007;32(1):76-88.
24. Despres JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E,et al. Abdominal obesity and the metabolic syndrome: contribu-tion to global cardiometabolic risk. Arterioscler Thromb Vasc Biol. 2008;28(6):1039-49.
25. Cameron AJ, Boyko EJ, Sicree RA, Zimmet PZ, Soderberg S, Alberti KG, et al. Central obesity as a precursor to the metabolicsyndrome in the AusDiab Study and Mauritius. Obesity (SilverSpring). 2008. [Epub ahead of print].
26. Lin LY, Kuo HK, Li HY, Hwang JJ, Lin JW. Confirming a biologicalpathway in the metabolic syndromeinsight from the NHANES 1999-2002. Obesity (Silver Spring). 2008. [Epub ahead of print].
27. Reaven GM. Insulin resistance, the insulin resistance syndrome,and cardiovascular disease. Panminerva Med. 2005;47(4):201-10.
28. Shehata MF. Genetic and dietary salt contributors to insulin resistance in Dahl saltsensitive (S) rats. Cardiovasc Diabetol. 2008;7:7.
29. Ruivo GF, Leandro SM, do Nascimento CA, Catanozi S, Rocha JC, Furukawa LN, et al. Insulin resistance due to chronic salt restriction is corrected by alpha and beta blockade and by Larginine. Physiol Behav. 2006;88(4-5):364-70.
30. Donovan DS, Solomon CG, Seely EW, Williams GH, Simonson DC. Effect of sodium intake on insulin sensitivity. Am J Physiol. 1993;264(5 Pt 1):E730-4.
31. Foo M, Denver AE, Coppack SW, Yudkin JS. Effect of saltloadingon blood pressure, insulin sensitivity and limb blood flow in normal subjects. Clin Sci (Lond). 1998;95(2):157-64.
32. Raji A, Williams GH, Jeunemaitre X, Hopkins PN, Hunt SC, Hollenberg NK, et al. Insulin resistance in hypertensives: effect ofsalt sensitivity, renin status and sodium intake. J Hypertens. 2001;19(1):99-105.
33. Strazzullo P, Barbato A, Galletti F, Barba G, Siani A, Iacone R, et al. Abnormalities of renal sodium handling in the metabolicsyndrome. Results of the Olivetti Heart Study. J Hypertens. 2006;24(8):1633-9.
34. Sarafidis PA, Bakris GL. The antinatriuretic effect of insulin: an unappreciated mechanism for hypertension associated with insulinresistance? Am J Nephrol. 2007;27(1):44-54.
35. Ohta Y, Tsuchihashi T, Arakawa K, Onaka U, Ueno M. Prevalenceand lifestyle characteristics of hypertensive patients with metabolic syndrome followed at an outpatient clinic in Fukuoka, Japan. Hypertens Res. 2007;30(11):1077-82.
36. Hoffmann IS, Cubeddu LX. Salt and the metabolic syndrome.Nutr Metab Cardiovasc Dis. 2009;19(2):123-8.
37. Nakandakare ER, Charf AM, Santos FC, Nunes VS, Ortega K, Lottenberg AM, et al. Dietary salt restriction increases plasma lipoprotein and inflammatory marker concentrations in hypertensivepatients. Atherosclerosis. 2008;200(2):410-6.
38. Jurgens G, Graudal NA. Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines,cholesterols, and triglyceride. Cochrane Database Syst Rev. 2004;(1):CD004022.
39. Lien LF, Brown AJ, Ard JD, Loria C, Erlinger TP, Feldstein AC, etal. Effects of PREMIER lifestyle modifications on participantswith and without the metabolic syndrome. Hypertension. 2007;50(4):609-16.
40. Ard JD, Grambow SC, Liu D, Slentz CA, Kraus WE, Svetkey LP, etal. The effect of the PREMIER interventions on insulin sensitivity.Diabetes Care. 2004;27(2):340-7.
41. Townsend RR, Kapoor S, McFadden CB. Salt intake and insulin sensitivity in healthy human volunteers. Clin Sci (Lond). 2007;113(3):141-8.
42. Straznicky NE, Lambert EA, Lambert GW, Masuo K, Esler MD, Nestel PJ. Effects of dietary weight loss on sympathetic activityand cardiac risk factors associated with the metabolic syndrome. J Clin Endocrinol Metab. 2005;90(11):5998-6005.
43. Hoffmann IS, Cubeddu LX. Increased blood pressure reactivityto dietary salt in patients with the metabolic syndrome. J HumHypertens. 2007;21(6):438-44.
44. Uzu T, Kimura G, Yamauchi A, Kanasaki M, Isshiki K, Araki S, etal. Enhanced sodium sensitivity and disturbed circadian rhythmof blood pressure in essential hypertension. J Hypertens. 2006;24(8):1627-32.
45. Vedovato M, Lepore G, Coracina A, Dodesini AR, Jori E, Tiengo A, et al. Effect of sodium intake on blood pressure and albuminuriain Type 2 diabetic patients: the role of insulin resistance. Diabetologia. 2004;47(2):300-3.
46. Azadbakht L, Mirmiran P, Esmaillzadeh A, Azizi T, Azizi F. Beneficial effects of a Dietary Approaches to Stop Hypertension eatingplan on features of the metabolic syndrome. Diabetes Care. 2005;28(12):2823-31.
47. Gomi T, Shibuya Y, Sakurai J, Hirawa N, Hasegawa K, Ikeda T. Strictdietary sodium reduction worsens insulin sensitivity by increasing sympathetic nervous activity in patients with primary hypertension. Am J Hypertens. 1998;11(9):1048-55.
48. He FJ, MacGregor GA. Effect of longerterm modest salt reduction on blood pressure. Cochrane Database Syst Rev. 2004;(3):CD004937.
49. Vogt TM, Appel LJ, Obarzanek E, Moore TJ, Vollmer WM, Svetkey LP, et al. Dietary approaches to stop hypertension: rationale, design, and methods. DASH Collaborative Research Group. J AmDiet Assoc. 1999;99(8 Suppl):S12-8.
50. Van Horn L, McCoin M, KrisEtherton PM, Burke F, Carson JA, Champagne CM, et al. The evidence for dietary prevention and treatment of cardiovascular disease. J Am Diet Assoc. 2008;108(2):287-331.
51. Klein S. Outcome success in obesity. Obes Res. 2001;9 Suppl 4:354S-8S.
52. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMAmodeling. Diabetes Care. 2004;27(6):1487-95.